Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	57.23	-11.82	-27.64
Graham Fair Price	41.29	4.21	2.98
PEG	-80.25	-0.03	0.16
Price/Book	-8.28	2.35	2.57
Price/Cash Flow	59.50	-5.22	-12.90
Prices/Earnings	54.14	-3.43	-7.47
Price/Sales	-54.14	259.38	565.57
Price/FCF	59.50	-5.22	-12.90
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	3510.17	-16.03	0.44
Operating Margin	-0.30	-19.12	-19.07
ROA	-100.00	-0.09	-0.04
ROE	-0.09	-0.17	-100.00
ROIC	-0.06	-0.12	-111.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.01	1.15	-98.80
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.45	-1.01	121.51
EPS QOQ	0.45	-1.06	132.22
FCF QOQ	-0.08	-1.26	-1454.76
Revenue QOQ	0.20	1.00	396.15
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	61.28	7.35	-88.01
Days Sales Outstanding (DSO)	116.90	903.10	672.52
Inventory Turnover	1.47	12.25	734.08
Debt/Capitalization	0.34	0.32	-5.56
Quick Ratio	3.92	4.22	7.60
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2.14	2.14	-0.09
Cash	2.39	2.39	-0.09
Capex	-0.32	-0.71	-121.84
Free Cash Flow	-0.43	-0.96	-126.25
Revenue	< 0.005	0.02	99.81
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	4.29	4.29	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.27	4.03	-51.29
Naive Interpretation	Member

06 - Financial Health · Bad

Rating